A Cancer Risk Assessment of Di(2-ethylhexyl)phthalate: Application of the New U.S. EPA Risk Assessment Guidelines

Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia

Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217

Targeted Disruption of the α Isoform of the Peroxisome Proliferator-Activated Receptor Gene in Mice Results in Abolishment of the Pleiotropic Effects of Peroxisome Proliferators

Lee, S. S.-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655

IARC (International Agency for Research on Cancer)

Toporcov, T. N., & Filho, V. W. (2018) · Cited by 1,178

A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug.

Lazarow, P. B., & De Duve, C. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.6.2043 · Cited by 1,137

Carcinogenesis by Hepatic Peroxisome Proliferators: Evaluation of the Risk of Hypolipidemic Drugs and Industrial Plasticizers to Humans

Reddy, J. K., Lalvvai, N. D., & Farber, E. (1983) · CRC Critical Reviews in Toxicology · doi:10.3109/10408448309029317 · Cited by 879

Tissue Distribution and Quantification of the Expression of mRNAs of Peroxisome Proliferator–Activated Receptors and Liver X Receptor-α in Humans: No Alteration in Adipose Tissue of Obese and NIDDM Patients

Auboeuf, D., Rieusset, J., Fajas, L., Vallier, P., Frering, V., Riou, J. P., Staels, B., Auwerx, J., Laville, M., & Vidal, H. (1997) · Diabetes · doi:10.2337/diab.46.8.1319 · Cited by 697

Short-term tests for carcinogens and mutagens

Hollstein, M., McCann, J., Angelosanto, F. A., & Nichols, W. W. (1979) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(79)90014-9 · Cited by 685

Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643

Peters, J. (1997) · Carcinogenesis · doi:10.1093/carcin/18.11.2029 · Cited by 479

Neoplastic and nonneoplastic lesions in aging F344 rats

GOODMAN, D. (1979) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(79)90029-2 · Cited by 461

Peroxisome proliferator activated receptor-alpha expression in human liver.

Palmer, C. N., Hsu, M. H., Griffin, K. J., Raucy, J. L., & Johnson, E. F. (1998) · PubMed · Cited by 448

Peroxisomal Lipid Metabolism

Reddy, J. K., & Mannaerts, G. P. (1994) · Annual Review of Nutrition · doi:10.1146/annurev.nu.14.070194.002015 · Cited by 417

Peroxisome Proliferator Activated Receptor-α Expression in Human Liver

Palmer, C. N. A., Hsu, M.-H., Griffin, K. J., Raucy, J. L., & Johnson, E. F. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.1.14 · Cited by 416

Migration of a Phthalate Ester Plasticizer from Polyvinyl Chloride Blood Bags into Stored Human Blood and Its Localization in Human Tissues

Jaeger, R. J., & Rubin, R. J. (1972) · New England Journal of Medicine · doi:10.1056/nejm197211302872203 · Cited by 400

Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats.

Marsman, D. S., Cattley, R. C., Conway, J. G., & Popp, J. A. (1988) · PubMed · Cited by 353

Isolation and Characterization of PBP, a Protein That Interacts with Peroxisome Proliferator-activated Receptor

Zhu, Y., Qi, C., Jain, S., Rao, M. S., & Reddy, J. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25500 · Cited by 346

Steatohepatitis, Spontaneous Peroxisome Proliferation and Liver Tumors in Mice Lacking Peroxisomal Fatty Acyl-CoA Oxidase

Fan, C.-Y., Pan, J., Usuda, N., Yeldandi, A. V., Rao, M. S., & Reddy, J. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15639 · Cited by 343

Mechanistically-based Human Hazard Assessment of Peroxisome Proliferator-induced Hepatocarcinogenesis

Ashby, J., Brady, A., Elcombe, C. R., Elliott, B. M., Ishmael, J., Odum, J., Tugwood, J. D., Kettle, S., & Purchase, I. F. H. (1994) · Human & Experimental Toxicology · doi:10.1177/096032719401300201 · Cited by 313

Hepatocarcinogenic Potential of Di(2-Ethylhexyl)phthalate in Rodents and its Implications on Human Risk

Huber, W. W., Grasl-kraupp, B., & Schulte-hermann, R. (1996) · Critical Reviews in Toxicology · doi:10.3109/10408449609048302 · Cited by 302

Hepatic peroxisome proliferation in rodents and its significance for humans

Bentley, P., Calder, I., Elcombe, C., Grasso, P., Stringer, D., & Wiegand, H.-J. (1993) · Food and Chemical Toxicology · doi:10.1016/0278-6915(93)90225-n · Cited by 271

Cytochromes P450. Metabolic and Toxicological Aspects

Shuster, L. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199708000-00025 · Cited by 271

Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators

Mukherjee, R., Jow, L., Noonan, D., & McDonnell, D. P. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90089-2 · Cited by 270

Metabolism of diethylhexyl phthalate by rats

Albro, P. W., Thomas, R., & Fishbein, L. (1973) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)96915-8 · Cited by 269

Receptor and Nonreceptor-Mediated Organ-Specific Toxicity of Di(2-ethylhexyl)phthalate (DEHP) in Peroxisome Proliferator-Activated Receptorα-Null Mice

Ward, J. M., Peters, J. M., Perella, C. M., & Gonzalez, F. J. (1998) · Toxicologic Pathology · doi:10.1177/019262339802600208 · Cited by 249

Do Peroxisome Proliferating Compounds Pose a Hepatocarcinogenic Hazard to Humans?

Cattley, R. C., DeLuca, J., Elcombe, C., Fenner-Crisp, P., Lake, B. G., Marsman, D. S., Pastoor, T. A., Popp, J. A., Robinson, D. E., Schwetz, B., et al. (1998) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.1997.1163 · Cited by 244

Cytochromes P450: Metabolic and Toxicological Aspects

Ioannides, C. (1996) · Medical Entomology and Zoology · Cited by 220

Hepatic peroxisome (microbody) proliferation in rats fed plasticizers and related compounds

Moody, D. E., & Reddy, J. K. (1978) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(78)90111-4 · Cited by 220

Pharmacokinetics, interactions with macromolecules and species differences in metabolism of DEHP.

Albro, P. W., Corbett, J. T., Schroeder, J. L., Jordan, S., & Matthews, H. B. (1982) · Environmental Health Perspectives · doi:10.1289/ehp.824519 · Cited by 215

Studies on the hepatic effects of orally administered di-(2-ethylhexyl) phthalate in the rat

Lake, B. G., Gangolli, S. D., Grasso, P., & Lloyd, A. G. (1975) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(75)90226-4 · Cited by 201

Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferator, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14, 643), in rat and mouse liver.

Jk, R., Rao, M. S. R., Dl, A., & Sell, S. (1979) · PubMed · Cited by 179

Peroxisome proliferation due to di(2-ethylhexyl) phthalate (DEHP): species differences and possible mechanisms.

Elcombe, C. R., & Mitchell, A. M. (1986) · Environmental Health Perspectives · doi:10.1289/ehp.8670211 · Cited by 176

PPAR: a mediator of peroxisome proliferator action

Green, S. (1995) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/0027-5107(95)00136-0 · Cited by 176

Mechanisms of Hepatocarcinogenicity of Peroxisome-Proliferating Drugs and Chemicals

Lake, B. G. (1995) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.002411 · Cited by 168

Peroxisome Proliferator-activated Receptor Mediates Cross-talk with Thyroid Hormone Receptor by Competition for Retinoid X Receptor

Juge-Aubry, C. E., Gorla-Bajszczak, A., Pernin, A., Lemberger, T., Wahli, W., Burger, A., & Meier, C. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.30.18117 · Cited by 155

Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients

Auboeuf, D., Rieusset, J., Lluis Fajas, A., Vallier, P., Frering, V., Riou, J. P., Staels, B., Auwerx, J. H., Laville, M., & Vidal, H. (1997) · Diabetes · doi:10.2337/diabetes.46.8.1319 · Cited by 152

Tumorigenicity of the hypolipidaemic peroxisome proliferator ethyl-alpha-p-chlorophenoxyisobutyrate (clofibrate) in rats.

Reddy, J. K., & Qureshi, S. A. (1979) · British Journal of Cancer · doi:10.1038/bjc.1979.203 · Cited by 148

Peroxisome Proliferator‐activated Receptors: Stuctures and Function

Tugwood, J. D., Aldridge, T. C., Lambe, K. G., MACDONALD, N., & Woodyatt, N. J. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18620.x · Cited by 145

Malignant Tumors in Rats Fed Nafenopin, a Hepatic Peroxisome Proliferator 2

Reddy, J. K., & Rao, M. S. (1977) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/59.6.1645 · Cited by 142

Young Scientists Award Lecture 1984: Species Differences in Carcinogenicity and Peroxisome Proliferation due to Trichloroethylene: A Biochemical Human Hazard Assessment

Elcombe, C. R. (1985) · Archives of toxicology. Supplement · doi:10.1007/978-3-642-69928-3_2 · Cited by 138

Comparative Pharmacokinetics and Subacute Toxicity of Di(2-Ethylhexyl) Phthalate (DEHP) in Rats and Marmosets: Extrapolation of Effects in Rodents to Man

Rhodes, C. J., Orton, T. C., Pratt, I. S., Batten, P. L., Bratt, H., Jackson, S., & Elcombe, C. R. (1986) · Environmental Health Perspectives · doi:10.1289/ehp.8665299 · Cited by 135

Induction of hepatic peroxisome proliferation in nonrodent species, including primates.

Reddy, J. K., Lalwani, N. D., Qureshi, S. A., Reddy, M. K., & Moehle, C. M. (1984) · PubMed · Cited by 134

Relationship between morphological changes and lipid-lowering action of -chlorphenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man

Hanefeld, M., Kemmer, C., & KADNER, E. (1983) · Atherosclerosis · doi:10.1016/0021-9150(83)90115-6 · Cited by 133

Metabolism of DI(2=Ethylhexyl)Phthalate

Albro, P. W., & Lavenhar, S. R. (1989) · Drug Metabolism Reviews · doi:10.3109/03602538909029953 · Cited by 130

Peroxisomes: Biology and Importance in Toxicology and Medicine

Lake, R. (2007) · Cited by 130

Use of primary cultures of human hepatocytes in toxicology studies.

Butterworth, B. E., Smith-Oliver, T. A., Earle, L., Loury, D. J., White, R. D., Doolittle, D. J., Working, P. K., Cattley, R. C., Jirtle, R. L., & Michalopoulos, G. K. (1989) · PubMed · Cited by 121

Identification of the proximate peroxisome proliferator(s) derived from Di(2-ethylhexyl) phthalate

Mitchell, A. M., Lhuguenot, J., Bridges, J. W., & Elcombe, C. R. (1985) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(85)90097-3 · Cited by 120

Time and dose-response study of the effects on rats of the plasticizer di(2-ethylhexyl) phthalate

Mitchell, F. E. (1985) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(85)90409-0 · Cited by 119

The Orphan Nuclear Hormone Receptor LXRα Interacts with the Peroxisome Proliferator-activated Receptor and Inhibits Peroxisome Proliferator Signaling

Miyata, K., McCaw, S. E., Patel, H. V., Rachubinski, R. A., & Capone, J. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9189 · Cited by 118

Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig, and marmoset

Lake, B. G., Evans, J. G., Gray, T. J. B., Körösi, S. A., & North, C. J. (1989) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(89)90120-8 · Cited by 116

Circulating concentrations of di(2-ethylhexyl) phthalate and its de-esterified phthalic acid products following plasticizer exposure in patients receiving hemodialysis

Pollack, G. M., Buchanan, J. F., Slaughter, R. L., Kohli, R. K., & Shen, D. D. (1985) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(85)90347-3 · Cited by 116

Inhibitory effect of antioxidants ethoxyquin and 2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator.

Rao, M. S. R., Nd, L., Tk, W., et al. (1984) · PubMed · Cited by 107

Absorption, Metabolism, and Excretion of Di(2-Ethylhexyl) Phthalate by Rats and Mice

Albro, P. W. (1986) · Environmental Health Perspectives · doi:10.1289/ehp.8665293 · Cited by 107

An overview of peroxisome proliferator-induced hepatocarcinogenesis.

Rao, M. S. R., & Reddy, J. K. (1991) · Environmental Health Perspectives · doi:10.1289/ehp.9193205 · Cited by 107

Phthalate Esters and Their Effect on the Liver

Ganning, A. E., Brunk, U. T., & Dallner, G. (1984) · Hepatology · doi:10.1002/hep.1840040331 · Cited by 107

Light and electron microscopy of liver in hyperlipoproteinemic patients under long-term gemfibrozil treatment

de la Iglesia, F. A., Lewis, J. E., Buchanan, R. A., Marcus, E., & McMahon, G. (1982) · Atherosclerosis · doi:10.1016/0021-9150(82)90096-x · Cited by 103

Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis

James, N. H., & Roberts, R. A. (1996) · Carcinogenesis · doi:10.1093/carcin/17.8.1623 · Cited by 103

Influence of fenofibrate on cellular and subcellular liver structure in hyperlipidemic patients

Blümcke, S., Schwartzkopff, W., Lobeck, H., Edmondson, N. A., Prentice, D. A., & Blane, G. F. (1983) · Atherosclerosis · doi:10.1016/0021-9150(83)90169-7 · Cited by 102

Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously.

Kraupp-Grasl, B., Huber, W. W., Taper, H., & Schulte‐Hermann, R. (1991) · PubMed · Cited by 97

Chemically induced proliferation of peroxisomes: Implications for risk assessment

Stott, W. T. (1988) · Regulatory Toxicology and Pharmacology · doi:10.1016/0273-2300(88)90026-8 · Cited by 97

Significant Increase of 8‐Hydroxydeoxyguanosine in Liver DNA of Rats Following Short‐term Exposure to the Peroxisome Proliferators Di(2‐ethylhexyl)phthalate and Di(2‐ethylhexyl)adipate

Takagi, A., Sai, K., Umemura, T., Hasegawa, R., & Kurokawa, Y. (1990) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1990.tb02551.x · Cited by 94

The effect of beclobric acid and clofibric acid on peroxisomal β-oxidation and peroxisome proliferation in primary cultures of rat, monkey and human hepatocytes

Blaauboer, B. J., van Holsteijn, C. W. M., Bleumink, R., et al. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90551-u · Cited by 89

Testing for induction of DNA synthesis in human hepatocyte primary cultures by rat liver tumor promoters.

Parzefall, W., Erber, E., Sedivy, R., & Schulte‐Hermann, R. (1991) · PubMed · Cited by 87

A peroxisome proliferator-activated receptor-alpha (PPARα) cDNA cloned from guinea-pig liver encodes a protein with similar properties to the mouse PPARα: implications for species differences in responses to peroxisome proliferators

Tugwood, J. D., Holden, P. R., James, N. H., Prince, R. A., & Roberts, R. A. (1998) · Archives of Toxicology · doi:10.1007/s002040050483 · Cited by 87

Effects of route of administration and repetitive dosing on the disposition kinetics of di(2-ethylhexyl) phthalate and its mono-de-esterified metabolite in rats

Pollack, G. M., Li, R. C. K., Ermer, J. C., & Shen, D. D. (1985) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(85)90346-1 · Cited by 87

Kupffer cells are causally responsible for the mitogenic effect of peroxisome proliferators

Rose, M. (1997) · Carcinogenesis · doi:10.1093/carcin/18.8.1453 · Cited by 87

Delivery of di-2-ethylhexyl phthalate to patients during hemodialysis.

Tp, G., Briggs, W. A., & Bj, B. (1976) · PubMed · Cited by 87

The Accumulation of Mono‐2‐Ethylhexylphthalate (MEHP) During Storage of Whole Blood and Plasma

Rock, G. A., Secours, V. E., Franklin, C. A., Chu, I., & Villeneuve, D. C. (1978) · Transfusion · doi:10.1046/j.1537-2995.1978.18579036383.x · Cited by 85

Interaction of the peroxisome proliferator-activated receptor alpha with the retinoid X receptor alpha unmasks a cryptic peroxisome proliferator response element that overlaps an ARP-1-binding site in the CYP4A6 promoter.

Palmer, C. N., Hsu, M., Muerhoff, A. S., Griffin, K. J., & Johnson, E. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32420-1 · Cited by 83

The Human Peroxisome Proliferator-activated Receptor (PPAR) Subtype NUC1 Represses the Activation of hPPARα and Thyroid Hormone Receptors

Jow, L., & Mukherjee, R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.8.3836 · Cited by 83

Subchronic Toxicity of Di(2-ethylhexyl)phthalate in Common Marmosets: Lack of Hepatic Peroxisome Proliferation, Testicular Atrophy, or Pancreatic Acinar Cell Hyperplasia

Kurata, Y., Kidachi, F., Yokoyama, M., Toyota, N., Tsuchitani, M., & Katoh, M. (1998) · Toxicological Sciences · doi:10.1006/toxs.1997.2414 · Cited by 82

WY-14 643 rapidly activates nuclear factor kappaB in Kupffer cells before hepatocytes

Rusyn, I., Tsukamoto, H., & Thurman, R. G. (1998) · Carcinogenesis · doi:10.1093/carcin/19.7.1217 · Cited by 80

Inhibition of Peroxisome Proliferator Signaling Pathways by Thyroid Hormone Receptor

Miyamoto, T., Kaneko, A., Kakizawa, T., Yajima, H., Kamijo, K., Sekine, R., Hiramatsu, K., Nishii, Y., Hashimoto, T., & Hashizume, K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7752 · Cited by 79

Hepatic peroxisomal changes induced by a tetrazole-substituted akoxyacetophenone in rats and comparison with other species

Eacho, P. I. (1986) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(86)90225-5 · Cited by 79

Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, Wy-14,643

Marsman, D. S., & Popp, J. A. (1994) · Carcinogenesis · doi:10.1093/carcin/15.1.111 · Cited by 78

Peroxisomes

Gibson, G. G., & Lake, B. G. (2013) · CRC Press eBooks · doi:10.1201/9780203481516 · Cited by 77

Relationship between hepatic peroxisome proliferation and 8-hydroxydeoxyguanosine formation in liver DNA of rats following long-term exposure to three peroxisome proliferators; di(2-ethylhexyl) phthalate, aluminium clofibrate and simfibrate

Takagi, A., Sai, K., Umemura, T., Hasegawa, R., & Kurokawa, Y. (1990) · Cancer Letters · doi:10.1016/0304-3835(90)90007-k · Cited by 71

Effect of Rodent Hepatocarcinogenic Peroxisome Proliferators on Fatty Acyl-CoA Oxidase, DNA Synthesis, and Apoptosis in Cultured Human and Rat Hepatocytes

Perrone, C. E., Shao, L., & Williams, G. M. (1998) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1998.8413 · Cited by 71

Tumor promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in rat liver.

Kraupp-Grasl, B., Huber, W. W., Putz, B., Gerbracht, U., & Schulte‐Hermann, R. (1990) · PubMed · Cited by 70

Effects of a plasticizer leached from polyvinyl chloride on the subhuman primate: a consequence of chronic transfusion therapy.

Jacobson, M. S., Kevy, S. V., & Grand, R. J. (1977) · PubMed · Cited by 70

Metabolism and tissue distribution of mono-2-ethylhexyl phthalate in the rat.

Chu, I., Villeneuve, D. C., Secours, V. E., Franklin, C. A., Rock, G. A., & Viau, A. (1978) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06301-9 · Cited by 70

Molecular basis of non-responsiveness to peroxisome proliferators: the guinea-pig PPARα is functional and mediates peroxisome proliferator-induced hypolipidaemia

Bell, A. R., Savory, R., Horley, N., Choudhury, A. I., Dickins, M., Gray, T. J. B., Salter, A. M., & Bell, D. (1998) · Biochemical Journal · doi:10.1042/bj3320689 · Cited by 67

Biochemical studies on phthalic esters I. Elimination, distribution and metabolism of di-(2-ethylhexyl)phthalate in rats

Tanaka, A., Adachi, T., Takahashi, T., & Yamaha, T. (1975) · Toxicology · doi:10.1016/0300-483x(75)90105-5 · Cited by 67

Fate in Humans of the Plasticizer, Di‐2‐Ethylhexyl Phthalate, Arising from Transfusion of Platelets Stored in Vinyl Plastic Bags

Rubin, R. J., & Schiffer, C. (1976) · Transfusion · doi:10.1046/j.1537-2995.1976.16476247053.x · Cited by 67

Association of persistent peroxisome proliferation and oxidative injury with hepatocarcinogenicity in female F-334 rats fed di(2-ethylhexyl)phthalate for 2 years

Cattley, R. C., Conway, J. G., & Popp, J. A. (1987) · Cancer Letters · doi:10.1016/0304-3835(87)90195-9 · Cited by 67

DI(2-ethylhexyl) phthalate

Schmezer, P. (1989) · Food and Chemical Toxicology · doi:10.1016/0278-6915(89)90174-9 · Cited by 66

Effects of -chlorophenoxyisobutyric acid (CPIB) on the human liver

Hanefeld, M., Kemmer, C., Leonhardt, W., Kunze, K. D., Jaroß, W., & HALLER, H. (1980) · Atherosclerosis · doi:10.1016/0021-9150(80)90225-7 · Cited by 62

Di‐2‐Ethylhexyl Phthalate (DEHP) and Mono‐2‐Ethylhexyl Phthalate (MEHP) Accumulation in Whole Blood and Red Cell Concentrates

Peck, C. C., Odom, D. G., Friedman, H. I., Albro, P. W., Hass, J. R., Brady, J., & Jess, D. A. (1979) · Transfusion · doi:10.1046/j.1537-2995.1979.19279160282.x · Cited by 59

Identification of the metabolites of di-(2-ethylhexyl) phthalate in urine from the African green monkey.

Albro, P. W., Hass, J. R., Peck, C. C., Odam, D. G., Corbett, J. T., Bailey, F. J., Blatt, H. E., & Barrett, B. B. (1981) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06133-1 · Cited by 59

Sequential histologic study of rat liver during peroxisome proliferator [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]-acetic acid (Wy-14,643)-induced carcinogenesis.

Rao, M. S., Lalwani, N. D., & Reddy, J. K. (1984) · PubMed · Cited by 57

Peroxisome proliferators activate Kupffer cells in vivo.

Bojes, H. K., & Thurman, R. G. (1996) · PubMed · Cited by 56

Morphometric study of human hepatic cell modifications induced by fenofibrate

Gariot, P., Barrat, E., Drouin, P., et al. (1987) · Metabolism · doi:10.1016/0026-0495(87)90177-6 · Cited by 54

Peroxisome proliferation: current mechanisms relating to nongenotoxic carcinogenesis

Lake, B. G. (1995) · Toxicology Letters · doi:10.1016/0378-4274(95)03513-3 · Cited by 52

Species differences in the effects of bezafibrate, a hypolipidemic agent, on hepatic peroxisome-associated enzymes

Watanabe, T., Horie, S., Yamada, J., et al. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90051-8 · Cited by 51

A single amino acid change in the mouse peroxisome proliferator-activated receptor alpha alters transcriptional responses to peroxisome proliferators.

Hsu, M. H., Palmer, C. N., Griffin, K. J., & Johnson, E. F. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10506-3 · Cited by 49

Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster.

Lake, B. G., Evans, J. G., Cunninghame, M. E., & Price, R. J. (1993) · Environmental Health Perspectives · doi:10.1289/ehp.93101s5241 · Cited by 47

Species differences in ciprofibrate induction of hepatic cytochrome p450 4A1 and peroxisome proliferation

Makowska, J. M., Gibson, G. G., & Banner, F. W. (1992) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.2570070308 · Cited by 46

Non‐genotoxic Hepatocarcinogenesis: Suppression of Apoptosis by Peroxisome Proliferators

Roberts, R. A. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18647.x · Cited by 44

Absence of γ-glutamyl transpeptidase activity in neoplastic lesions induced in the liver of male F-344 rats by di-(2-ethylhexyl)phthalate, a peroxisome proliferator

Rao, M. S., Usuda, N., Subbarao, V., et al. (1987) · Carcinogenesis · doi:10.1093/carcin/8.9.1347 · Cited by 43

Fenofibrate: Metabolism and Species Differences for Peroxisome Proliferation in Cultured Hepatocytes

Chagnon, M. (1995) · Fundamental and Applied Toxicology · doi:10.1006/faat.1995.1075 · Cited by 41

Peroxisome Proliferators: Species Differences in Response of Primary Hepatocyte Cultures

Elcombe, C. R., Bell, D., Elias, E., Hasmall, S. C., & Plant, N. J. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18649.x · Cited by 40

Mechanism‐based Risk Assessment of Peroxisome Proliferating Rodent Hepatocarcinogens

Williams, G. M., & Perrone, C. E. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb18645.x · Cited by 37

Lack of Peroxisome Proliferation in Marmoset Liver Following Treatment with Ciprofibrate for 3 Years

Graham, M. (1994) · Fundamental and Applied Toxicology · doi:10.1006/faat.1994.1008 · Cited by 35

Comparative Toxicology of Hypolipidaemic Fibrates

NORTHUP, S. J. (1996) · Journal of the American College of Toxicology · doi:10.3109/10915819609018014 · Cited by 29

The peroxisome proliferators are hepatocyte mitogens in chemically- defined media: glucocorticoid-induced PPAR alpha is linked to peroxisome proliferator mitogenesis

Plant, N. J. (1998) · Carcinogenesis · doi:10.1093/carcin/19.5.925 · Cited by 29

Non-linearities in the pharmacokinetics of di-(2-ethylhexyl) phthalate and metabolites in male rats

Sj�berg, P., Bondesson, U., & Hammarlund, M. (1985) · Archives of Toxicology · doi:10.1007/bf00348312 · Cited by 24

Structure-activity relationships for induction of peroxisomal enzyme activities in primary rat hepatocyte cultures

Lake, B. G., Lewis, D. F. V., Gray, T. J. B., & Beamand, J. A. (1993) · Toxicology in Vitro · doi:10.1016/0887-2333(93)90094-l · Cited by 20

Acyl CoA oxidase is the most suitable marker for hepatic peroxisomal changes caused by treatment of F344 rats with Di(2-ethylhexyl)phthalate

Tomaszewski, K. E., Derks, M. C., & Melnick, R. L. (1987) · Toxicology Letters · doi:10.1016/0378-4274(87)90133-0 · Cited by 20

Risk to human health related to the presence of perfluoroalkyl substances in food

Panel), E. P. O. C. I. T. F. C. (. C., Schrenk, D., Bignami, M., Bodin, L., Chipman, J. K., del Mazo, J., Grasl‐Kraupp, B., Hogstrand, C., Hoogenboom, L. (., Leblanc, J., et al. (2020) · EFSA Journal · doi:10.2903/j.efsa.2020.6223 · Cited by 989

Phthalates and human health

Hauser, R., & Calafat, A. M. (2005) · Occupational and Environmental Medicine · doi:10.1136/oem.2004.017590 · Cited by 941

The toxicology of perfluorooctanoate

Kennedy, G. L., Butenhoff, J. L., Olsen, G. W., O'Connor, J. C., Seacat, A. M., Perkins, R. G., Biegel, L. B., Murphy, S. R., & Farrar, D. G. (2004) · Critical Reviews in Toxicology · doi:10.1080/10408440490464705 · Cited by 742

Levels of Seven Urinary Phthalate Metabolites in a Human Reference Population

Blount, B. C., Silva, M. J., Caudill, S. P., Needham, L. L., Pirkle, J. L., Sampson, E. J., Lucier, G. W., Jackson, R. J., & Brock, J. W. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.00108979 · Cited by 634

Di(2‐ethylhexyl)phthalate (DEHP): human metabolism and internal exposure – an update and latest results1

Koch, H. M., Preuss, R., & Angerer, J. (2006) · International Journal of Andrology · doi:10.1111/j.1365-2605.2005.00607.x · Cited by 590